2clz
From Proteopedia
Line 1: | Line 1: | ||
[[Image:2clz.gif|left|200px]] | [[Image:2clz.gif|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_2clz", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | | | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), |
- | | | + | or leave the SCENE parameter empty for the default display. |
- | + | --> | |
- | + | {{STRUCTURE_2clz| PDB=2clz | SCENE= }} | |
- | + | ||
- | + | ||
- | }} | + | |
'''MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE''' | '''MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE''' | ||
Line 34: | Line 31: | ||
[[Category: Roussel, A.]] | [[Category: Roussel, A.]] | ||
[[Category: Schmitt-Verhulst, A M.]] | [[Category: Schmitt-Verhulst, A M.]] | ||
- | [[Category: | + | [[Category: Alloreactivity]] |
- | [[Category: | + | [[Category: Class i mhc]] |
- | [[Category: | + | [[Category: Glycoprotein]] |
- | [[Category: | + | [[Category: H-2kbm8]] |
- | [[Category: | + | [[Category: Immune response]] |
- | [[Category: | + | [[Category: Immune system]] |
- | [[Category: | + | [[Category: Immunoglobulin domain]] |
- | [[Category: | + | [[Category: Membrane]] |
- | [[Category: | + | [[Category: Mhc i]] |
- | [[Category: | + | [[Category: Polymorphism]] |
- | [[Category: | + | [[Category: Transmembrane]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 22:28:02 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 19:28, 3 May 2008
MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE
Overview
We have characterized three different programs of activation for alloreactive CD8 T cells expressing the BM3.3 TCR, their elicitation depending on the characteristics of the stimulating peptide/MHC complex. The high-affinity interaction between the TCR and the K(b)-associated endogenous peptide pBM1 (INFDFNTI) induced a complete differentiation program into effector cells correlated with sustained ERK activation. The K(bm8) variant elicited a partial activation program with delayed T cell proliferation, poor CTL activity and undetectable ERK phosphorylation; this resulted from a low-avidity interaction of TCR BM3.3 with a newly identified endogenous peptide, pBM8 (SQYYYNSL). Interestingly, mismatched pBM1/K(bm8) complexes induced a split response in BM3.3 T cells, with total reconstitution of T cell proliferation but defective generation of CTL activity that was correlated with strong but shortened ERK phosphorylation. Crystal structures highlight the molecular basis for the higher stability of pBM8/K(bm8) compared to pBM1/K(bm8) complexes that exist in two conformers. This study illustrates the importance of the stability of both peptide/MHC and peptide/MHC-TCR interactions for induction of sustained signaling required to induce optimal CTL effector functions. Subtle allelic structural variations, amplified by peptide selection, may thus orient distinct outcomes of alloreactive TCR-based therapies.
About this Structure
2CLZ is a Protein complex structure of sequences from Mus musculus. Full crystallographic information is available from OCA.
Reference
Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes., Auphan-Anezin N, Mazza C, Guimezanes A, Barrett-Wilt GA, Montero-Julian F, Roussel A, Hunt DF, Malissen B, Schmitt-Verhulst AM, Eur J Immunol. 2006 Jul;36(7):1856-66. PMID:16761314 Page seeded by OCA on Sat May 3 22:28:02 2008
Categories: Mus musculus | Protein complex | Auphan-Anezin, N. | Barrett-Wilt, G A. | Guimezanes, A. | Hunt, D F. | Malissen, B. | Mazza, C. | Montero-Julian, F. | Roussel, A. | Schmitt-Verhulst, A M. | Alloreactivity | Class i mhc | Glycoprotein | H-2kbm8 | Immune response | Immune system | Immunoglobulin domain | Membrane | Mhc i | Polymorphism | Transmembrane